AXE archer materials limited

Ann: Improved Biochip Accuracy Paves Way for Human Blood Testing, page-6

  1. 388 Posts.
    lightbulb Created with Sketch. 321
    Woohoo! Love a good announcement, and this one is actually pretty solid, not groundbreaking, but definitely a meaningful step forward. The big win here I think is the huge improvement in sensor accuracy, which is a critical milestone for making the Biochip reliable enough for use in the real world.Moving from mock samples to actual human blood testing is another MAJOR leap because it shows they’re getting closer to proving this thing actually works outside a lab. The prototype cartridge system by the end of 2025 is promising, and if they stick to their plan, clinical trials in 2026 put them on track for eventual commercialisation, something I know everyone holding is looking forward to. Still a long road ahead in terms of regulatory approvals and clinical trials but this shows progress in the right direction and boosts my confidence in them!
    Last edited by milehighclub: 25/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
27.0¢
Change
0.000(0.00%)
Mkt cap ! $68.80M
Open High Low Value Volume
27.0¢ 27.5¢ 26.5¢ $39.48K 146.1K

Buyers (Bids)

No. Vol. Price($)
4 71996 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 77572 1
View Market Depth
Last trade - 15.37pm 17/06/2025 (20 minute delay) ?
AXE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.